1. Home
  2. FGBI vs GNLX Comparison

FGBI vs GNLX Comparison

Compare FGBI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

N/A

Current Price

$8.26

Market Cap

128.1M

Sector

Finance

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.63

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
GNLX
Founded
1934
2001
Country
United States
United States
Employees
339
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
113.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FGBI
GNLX
Price
$8.26
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$19.80
AVG Volume (30 Days)
6.3K
153.7K
Earning Date
05-11-2026
03-19-2026
Dividend Yield
0.48%
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
N/A
$8,000.00
Revenue This Year
$567.70
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$1.99
52 Week High
$10.55
$8.54

Technical Indicators

Market Signals
Indicator
FGBI
GNLX
Relative Strength Index (RSI) 44.74 47.23
Support Level $8.18 $2.54
Resistance Level $8.33 $3.00
Average True Range (ATR) 0.28 0.15
MACD -0.04 0.00
Stochastic Oscillator 18.93 47.16

Price Performance

Historical Comparison
FGBI
GNLX

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: